China Dealbook: AI startup Tianrang, biotech firm CureGenetics snag Series A

China Dealbook: AI startup Tianrang, biotech firm CureGenetics snag Series A

Artificial intelligence photo by Reuters

While Chinese artificial intelligence startup Tianrang has raised a RMB180 million ($26.3 million) round co-led by Gaorong Capital and CMB International, biotech firm CureGenetics has announced a $17 million Series A led by Qiming Venture Partners.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter